KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer

Waters, Andrew M., Der, Channing J.·2018·Cold Spring Harbor Perspectives in Medicine

DOI 10.1101/cshperspect.a031435

Cited by (882)

Items 301–400 of 882

Hydrophobic Tag Tethering Degradation, The Emerging Targeted Protein Degradation Strategy
Jieke Gao, Jiantao Zhang, Xiaoli Han, Jinming Zhou · 2022 · Current Medicinal Chemistry
Multiplex Digital Polymerase Chain Reaction on a Droplet Array SlipChip for Analysis of KRAS Mutations in Pancreatic Cancer
Qixin Hu, Fariha Kanwal, Weiyuan Lyu, Jiajie Zhang, Xu Liu, Kai Qin, Feng Shen · 2022 · ACS Sensors
Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
Eun-Kyoung Koh, Hong-Rae Lee, Woo-Chang Son, Ga‐Young Park, Juhee Kim, Jae-Ho Bae, You-Soo Park · 2023 · Scientific Reports
Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
Carina Peres, Ana I. Matos, Bárbara Carreira, Liane I.F. Moura, Ron Kleiner, Daniella Vaskovich‐Koubi, Keren Reshef, Shai Dulberg, Mafalda Verdial, João Conniot et al. · 2024 · Advanced Functional Materials
Tuft cells transdifferentiate to neural-like progenitor cells in the progression of pancreatic cancer
Daniel James Salas-Escabillas, Megan T. Hoffman, Sydney M. Brender, Jacee S. Moore, Hui‐Ju Wen, Simone Benitz, Erick T. Davis, Daniel Long, Allison M. Wombwell, Ella Rose D. Chianis et al. · 2024 · Developmental Cell
KRAS or BRAF mutations cause hepatic vascular cavernomas treatable with MAP2K–MAPK1 inhibition
Harish Palleti Janardhan, Xiuling Meng, Karen Dresser, Lloyd Hutchinson, Chinmay M. Trivedi · 2020 · The Journal of Experimental Medicine
Circular RNA hsa_circ_0006117 Facilitates Pancreatic Cancer Progression by Regulating the miR-96-5p/KRAS/MAPK Signaling Pathway
Tao Liu, Lei Zhou, Zhiwei He, Yankun Chen, Xueyi Jiang, Jian Xu, Jianxin Jiang · 2021 · Journal of Oncology
Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR–ABL–Positive Leukemia
Ziwei Luo, Chencen Lin, Chuwei Yu, Changxian Yuan, Wenyong Wu, Xiaowei Xu, Renhong Sun, Yan Jia, Yafang Wang, Jie Shen et al. · 2024 · Cancer Research
Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity
Husna Karaboga, Wentao Huang, Shivangi Srivastava, Scott Widmann, Sridevi Addanki, Kasuni Thawalama Gamage, Zahra Mazhar, Jerry Osagie Ebalunode, James M. Briggs, Jan-Ακε Gustafsson et al. · 2020 · ACS Chemical Biology
The next “sweet” spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection
Yuanwei Xu, Yuefan Wang, Naseruddin Höti, David J. Clark, Shao‐Yung Chen, Hui Zhang · 2021 · Mass Spectrometry Reviews
Targeting the “undruggable” RAS with biologics
Michael Whaby, Imran Khan, John P. O’Bryan · 2022 · Advances in cancer research
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
Amy Makler, Ramaswamy Narayanan, Waseem Asghar · 2022 · Biosensors
In Silico Study of the Acquired Resistance Caused by the Secondary Mutations of KRAS G12C Protein Using Long Time Molecular Dynamics Simulation and Markov State Model Analysis
Gao Tu, Qing Liu, Yue Qiu, Elaine Lai‐Han Leung, Xiaojun Yao · 2022 · International Journal of Molecular Sciences
Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening
Mohamed A Badheeb, Adham Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Karen Abboud, Ebtesam Al-Najjar, Gheith O Rasheed, Mohammed Alkhulaifawi, Ala Abudayyeh, Maen Abdelrahim · 2022 · Current Oncology
CDK9 inhibitors for the treatment of solid tumors
Christiana Mo, Ning Wei, T. Li, Muzaffer Ahmed Bhat, Mahshid Mohammadi, Chaoyuan Kuang · 2024 · Biochemical Pharmacology
Mir34a constrains pancreatic carcinogenesis
Ana Hidalgo‐Sastre, Clara Lubeseder–Martellato, Thomas Engleitner, Katja Steiger, Suyang Zhong, Judit Desztics, Rupert Öllinger, Roland Rad, Roland Michael Schmid, Heiko Hermeking et al. · 2020 · Scientific Reports
Targeting the ERK mitogen-activated protein kinase cascade for the treatment of KRAS-mutant pancreatic cancer
J. Nathaniel Diehl, Priya S. Hibshman, Irem Ozkan‐Dagliyan, Craig M. Goodwin, Sarah V. Howard, Adrienne D. Cox, Channing J. Der · 2022 · Advances in cancer research
c-Myc Protein Level Affected by Unsymmetrical Bisacridines Influences Apoptosis and Senescence Induced in HCT116 Colorectal and H460 Lung Cancer Cells
Monika Pawłowska, Jolanta Kulesza, Ewa Augustin · 2022 · International Journal of Molecular Sciences
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer
Christian Schneeweis, Sandra Diersch, Zonera Hassan, Lukas Krauß, Carolin Schneider, Daniele Lucarelli, Chiara Falcomatà, Katja Steiger, Rupert Öllinger, Oliver Holger Krämer et al. · 2022 · Cellular and Molecular Life Sciences
Polarization of Cancer-Associated Macrophages Maneuver Neoplastic Attributes of Pancreatic Ductal Adenocarcinoma
Huey-Jen L. Lin, Yingguang Liu, Kailey P. Caroland, Jiayuh Lin · 2023 · Cancers
Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer.
Fengna Liu, Aiai Gao, Meiying Zhang, Yazhuo Li, Fan Zhang, James Gordon Herman, Mingzhou Guo · 2024 · PubMed Central
Flavonoids as modulators of miRNA expression in pancreatic cancer: Pathways, Mechanisms, And Therapeutic Potential
Helen Helen, Mega Carensia Gunawan, Princella Halim, Muhammad Riza Dinata, Amer Ahmed, Aminah Dalimunthe, Marianne Marianne, Rosy Iara Maciel de Azambuja Ribeiro, Poppy Anjelisa Zaitun Hasibuan, Fahrul Nurkolis et al. · 2024 · Biomedicine & Pharmacotherapy
Analysis of Ras-effector interaction competition in large intestine and colorectal cancer context
Verónica Ibáňez Gaspar, Simona Catozzi, Camille Ternet, Philip J. Luthert, Christina Kiel · 2020 · Small GTPases
The unfolded protein response: An emerging therapeutic target for pancreatitis and pancreatic ductal adenocarcinoma
María Teresa Borrello, Mickenzie B. Martin, Christopher L. Pin · 2021 · Pancreatology
Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer
Leonel Pekarek, Oscar Fraile‐Μartinez, Cielo García Montero, Miguel A. Sáez, Ines Barquero-Pozanco, Laura del Hierro-Marlasca, Patricia De Castro-Martinez, Adoración Romero-Bazán, Miguel Ángel Álvarez-Mon, Jorge Monserrat et al. · 2022 · Cancers
ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1
Zhuo Shao, Chenggang Li, Qiao Wu, Xingmao Zhang, Yang Dai, Shenming Li, Xinyuan Liu, Xinying Zheng, Jiansheng Zhang, Hua Fan · 2022 · Oncogenesis
Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer
Sreejith Thrivikraman Nair, C Abhi, Kaladhar Kamalasanan, Keechilat Pavithran, Ashok R Unni, M S Sithara, Manjit Sarma, Thacho Sukumaran Mangalanandan · 2024 · Molecular Pharmaceutics
PAC-5 Gene Expression Signature for Predicting Prognosis of Patients with Pancreatic Adenocarcinoma
Jieun Kim, Yong Hwa Jo, Miran Jang, Ngoc Ngo Yen Nguyen, Hyeong Rok Yun, Seok Hoon Ko, Yoonhwa Shin, Ju‐Seog Lee, Insug Kang, Joohun Ha et al. · 2019 · Cancers
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
Stephen Lee Abrams, Przemysław Duda, Shaw M. Akula, Linda S. Steelman, Matilde L. Follo, Lucio Cocco, Stefano Ratti, Alberto Maria Martelli, Giuseppe Montalto, Maria Rita Emma et al. · 2022 · Cells
Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review)
Joshua H. Zhang, Lily Darman, Md Sazzad Hassan, Urs W. von Holzen, Niranjan Awasthi · 2023 · Oncology Reports
Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities
Ana Bogut, Bojan Stojanović, Marina Jovanović, Milica Dimitrijevic Stojanovic, Nevena Gajović, Bojana Stojanović, Goran Balovic, Milan Jovanovic, Aleksandar Lazovic, Milos Mirovic et al. · 2023 · International Journal of Molecular Sciences
The real-world study of the clinical characteristics, diagnosis, and treatment of advanced pancreatic cancer in China
Jiujie Cui, Qihan Fu, Xiaobing Chen, Yanling Wang, Qi Li, Feng Wang, Zhihua Li, Guanghai Dai, Yusheng Wang, Hongmei Zhang et al. · 2023 · Journal of Pancreatology
In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency
Casie S. Kubota, Stephanie L. Myers, Toni T. Seppälä, Richard Andrew Burkhart, Peter John Espenshade · 2024 · Molecular Metabolism
A novel terpenoid class for prevention and treatment of KRAS‐driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems
Arsheed Ahmad Ganaie, Hifzur Rahman Siddique, ISHFAQ AHMAD SHEIKH, Aijaz Parray, Lei Wang, Jayanth Panyam, Peter W. Villalta, Yibin Deng, Badrinath R. Konety, Mohammad Saleem · 2020 · Molecular Carcinogenesis
Intron retention is a robust marker of intertumoral heterogeneity in pancreatic ductal adenocarcinoma
Daniel J. Tan, Mithun Mitra, Alec M. Chiu, Hilary A. Coller · 2020 · npj Genomic Medicine
Not So Dead Genes—Retrocopies as Regulators of Their Disease-Related Progenitors and Hosts
Joanna Ciomborowska-Basheer, Klaudia Staszak, Magdalena Regina Kubiak, Izabela Makałowska · 2021 · Cells
A Transcriptionally Distinct Subpopulation of Healthy Acinar Cells Exhibit Features of Pancreatic Progenitors and PDAC
Vishaka Gopalan, Arashdeep Singh, Farid Rashidi Mehrabadi, Li Wang, Eytan Ruppin, H. Efsun Arda, Sridhar S. Hannenhalli · 2021 · Cancer Research
Multi-Omics Analysis of SOX4, SOX11, and SOX12 Expression and the Associated Pathways in Human Cancers
Jaekwon Seok, Minchan Gil, Ahmed Abdal Dayem, Subbroto Kumar Saha, Ssang‐Goo Cho · 2021 · Journal of Personalized Medicine
Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy
Hong Dai, Razack Abdullah, Xiaoqiu Wu, Fangfei Li, Yuan Ma, Aiping Lü, Ge Zhang · 2022 · Frontiers in Cell and Developmental Biology
Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival
Peter J. Bailey, Xu Zhou, Jingyu An, Teresa Peccerella, Kai Hu, Christoph Springfeld, Markus Wolfgang Büchler, John P. Neoptolemos · 2023 · Function
CYLD deficiency promotes pancreatic cancer development by causing mitotic defects
Songbo Xie, Yuhan Wu, Huijie Hao, Jingrui Li, Song Guo, Wei Dong Xie, Dengwen Li, Jun Zhou, Jinmin Gao, Min Liu · 2018 · Journal of Cellular Physiology
Targeting BCL2 with Venetoclax Enhances the Efficacy of the <i>KRAS</i> G12D Inhibitor MRTX1133 in Pancreatic Cancer
Becker, Jeffrey H., Metropulos, Anastasia E., Spaulding, Christina, Marinelarena, Alejandra M., Shields, Mario A., Principe, Daniel R., Pham, Thao D., Munshi, Hidayatullah G. · 2024 · Cancer Research
Mechanistic Foundations of KRAS‐Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment
Jiayao Ma, Shenao Fu, Jun Tan, Ying Han, Yihong Chen, Xiangying Deng, Hong Shen, Shan Zeng, Yinghui Peng, Changjing Cai · 2025 · Advanced Science
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer
Kathleen M. McAndrews, Francesca Paradiso, Clint A. Stalnecker, Benson Chellakkan Selvanesan, Fredrik I. Thege, David H. Peng, Barbara A. Moreno Diaz, Hikaru Sugimoto, Sarah I. Patel, Krishnan K. Mahadevan et al. · 2025 · Science Translational Medicine
Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis
Jacob Edward Till, Taylor A. Black, Caren Gentile, Aseel Abdalla, Zhuoyang Wang, Hareena K. Sangha, Jacquelyn J. Roth, Robyn T. Sussman, Stephanie S. Yee, Mark H. O’Hara et al. · 2021 · Journal of Molecular Diagnostics
DA-Raf and the MEK inhibitor trametinib reverse skeletal myocyte differentiation inhibition or muscle atrophy caused by myostatin and GDF11 through the non-Smad Ras–ERK pathway
Ryuichi Masuzawa, Kazuya Takahashi, Kazunori Takano, Ichizo Nishino, Toshiyuki Sakai, Takeshi Endo · 2021 · The Journal of Biochemistry
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
Αναστάσιος Γκουντάκος, Filippo Maria Martelli, Nicola Silvestris, Michele Bevere, Mario De Bellis, Laura Alaimo, Elena Sapuppo, Francesca Masetto, Aldo Mombello, Michele Simbolo et al. · 2023 · Cancers
Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake
Talia Golan, Raffaella Casolino, Andrew Victor Biankin, Pascal R. Hammel, Kristen Danielle Whitaker, Michael J. Hall, Douglas L. Riegert‐Johnson · 2023 · Therapeutic Advances in Medical Oncology
Targeted degradation of Pin1 by protein-destabilizing compounds
Giulia Alboreggia, Parima Udompholkul, Isaac Rodriguez, Gregor M. Blaha, Maurizio Pellecchia · 2024 · Proceedings of the National Academy of Sciences
KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism
Isaac James Muyinda, Jae Gwang Park, Eunjung Jang, Byong Chul Yoo · 2021 · International Journal of Molecular Sciences
Label-free enrichment of rare unconventional circulating neoplastic cells using a microfluidic dielectrophoretic sorting device
Jose Montoya Mira, Ajay A. Sapre, Brett S. Walker, Jesus Bueno, Kyle T. Gustafson, Eugene L. Tu, Jared Michael Fischer, Melissa Hirose Wong, Sadik C. Esener, Yu‐Jui Chiu · 2021 · Communications Biology
Integratively Genomic Analysis Reveals the Prognostic and Immunological Characteristics of Pyroptosis and Ferroptosis in Pancreatic Cancer for Precision Immunotherapy
Ting Yu, Huaicheng Tan, Chunhua Liu, Wen Nie, Yang Wang, Kexun Zhou, Shi H · 2022 · Frontiers in Cell and Developmental Biology
iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells
Boris Sieber, Fangfang Lu, Stephen M. Stribbling, Adam Graham Grieve, Anderson Joseph Ryan, Matthew Freeman · 2022 · Journal of Cell Science
Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society
Hongyu Zhang, Mi Deng, Peng Lin, Junjian Liu, Cheng Liu, William R. Strohl, Shouye Wang, Mitchell Ho · 2018 · Antibody Therapeutics
GVES: machine learning model for identification of prognostic genes with a small dataset
Soohyun Ko, Jonghwan Choi, Jaegyoon Ahn · 2021 · Scientific Reports
Therapeutic Targeting of Oncogene-Induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma
Shanna J. Smith, Fan Meng, Robert G. Lingeman, Caroline M. Li, Min Li, Galyah Boneh, Toni T. Seppälä, Thuy Xuan Phan, Haiqing Li, Richard A. Burkhart et al. · 2025 · Gastroenterology
The Diagnostic Accuracy of Mutant KRAS Detection from Pancreatic Secretions for the Diagnosis of Pancreatic Cancer: A Meta-Analysis
Nikhil Manish Patel, Tatjana Petrinic, Michael Silva, Zahir F. Soonawalla, Srikanth Reddy, Alex Nicolas Gordon-Weeks · 2020 · Cancers
MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer
Ammar Sarwar, Bo Wang, Qi Su, Yanmin Zhang · 2020 · Biochemical Pharmacology
Refining the Molecular Framework for Pancreatic Cancer with Single-cell and Spatial Technologies
Jimmy A. Guo, Hannah I. Hoffman, Colin D. Weekes, Lei Zheng, David Tsai Ting, William L. Hwang · 2021 · Clinical Cancer Research
Research progress of Bub3 gene in malignant tumors
Chenyang Wang, Dating Cheng, Chunyan Wang, Chunyan Wang, Zhi Nie · 2021 · Cell Biology International
Oncogenic Kras-Mediated Cytokine CCL15 Regulates Pancreatic Cancer Cell Migration and Invasion through ROS
Justin K. Messex, Kiyah L. Adams, William G. Hawkins, David G. DeNardo, Nabeel M. Bardeesy, Daniel D. Billadeau, Geou‐Yarh Liou · 2022 · Cancers
Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients
Joakin Mori, Jason B. White, Isra A. Elhussin, Babatunde Moses Duduyemi, Balasubramanyam Karanam, Clayton Clopton Yates, Honghe Wang · 2022 · Frontiers in Oncology
COL17A1 facilitates tumor growth and predicts poor prognosis in pancreatic cancer
Jian Yang, Yongzheng Li, Zhaowei Sun, Zhiyao Fan, Ming Shi, Shujie Liu, Yufan Meng, Bin Zhou, Yuanyuan Jiang, Hanxiang Zhan · 2022 · Biochemical and Biophysical Research Communications
Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers
Debbie Moss, Christopher K. McCann, Emma M. Kerr · 2022 · Science Signaling
Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond
Shaila A. Shetu, Nneoma James, Gildardo Rivera, Debasish Bandyopadhyay · 2023 · Current Issues in Molecular Biology
Emerging Prognostic and Predictive Factors in Pancreatic Cancer
Eva Karamitopoulou · 2023 · Modern Pathology
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition
Afsaneh Barzi, Caroline M. Weipert, Carin R. Espenschied, Victoria M. Raymond, Andrea Wang‐Gillam, Mohammad Amin Nezami, Eva J. Gordon, Daruka Mahadevan, Kabir Mody · 2024 · Frontiers in Oncology
Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations
Prasanna Mohite, Deepak K. Lokwani, Nikhil S. Sakle · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma
Gurkaranjot Singh, Drew Kutcher, Rajeshwar Lally, Vikrant Rai · 2024 · Cancers
SHANK3 depletion leads to ERK signalling overdose and cell death in KRAS-mutant cancers
Johanna Lilja, Jasmin Kaivola, James R. W. Conway, Joni Vuorio, Hanna Parkkola, Pekka Roivas, Michal Dibus, Megan R. Chastney, Taru Varila, Guillaume Jacquemet et al. · 2024 · Nature Communications
Pancreatic ductal adenocarcinoma in the era of precision medicine
Binbin Zheng-Lin, Eileen Mary O'Reilly · 2021 · Seminars in Oncology
KRAS Affects Adipogenic Differentiation by Regulating Autophagy and MAPK Activation in 3T3-L1 and C2C12 Cells
Wenjie Yu, Chengzhen Chen, Yanxia Peng, Ze Li, Yan Gao, Shuang Liang, Bao Yuan, Nam‐Hyung Kim, Hao Jiang, Jiabao Zhang · 2021 · International Journal of Molecular Sciences
Dynamic rewiring of biological activity across genotype and lineage revealed by context-dependent functional interactions
Eiru Kim, Lance C. Novak, Chenchu Lin, Medina Colic, Lori L. Bertolet, Veronica Gheorghe, Christopher Aaron Bristow, Traver Hart · 2022 · Genome biology
ACAGT-007a, an ERK MAPK Signaling Modulator, in Combination with AKT Signaling Inhibition Induces Apoptosis in KRAS Mutant Pancreatic Cancer T3M4 and MIA-Pa-Ca-2 Cells
Golam Iftakhar Khandakar, Ryosuke Satoh, Teruaki Takasaki, Kana Fujitani, Genzoh Tanabe, Kazuko Sakai, Kazuto Nishio, Reiko Sugiura · 2022 · Cells
Tumor Microenvironment Role in Pancreatic Cancer Stem Cells
Aaron Galindo-Vega, Vilma Maldonado, Irma Beatriz Mitre-Aguilar, Jorge Meléndez-Zajgla · 2023 · Cells
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
Yu-Ching Fan, Yu-Cin Fong, Chun‐Tse Kuo, Chia-Wei Li, Wei‐Yu Chen, Jian-Da Lin, Florian Bürtin, Michael Linnebacher, Quoc Thang Bui, Kuan‐Der Lee et al. · 2023 · Cell & Bioscience
Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer
Diego J. Jiménez, Aadil Javed, Teresa Rubio‐Tomás, Ndioba Seye-Loum, Carles Barceló · 2024 · International Journal of Molecular Sciences
MicroRNA-34 and gastrointestinal cancers: a player with big functions
Wei Gao, Jianping Zhou, Mohammadamin Morshedi · 2024 · Cancer Cell International
Targeting KRAS ‐mutant pancreatic cancer through simultaneous inhibition of KRAS , MEK, and JAK2
Satoru Miyazaki, Masato Kitazawa, Satoshi Nakamura, Makoto Koyama, Yuta Yamamoto, Nao Hondo, Masahiro Kataoka, Hirokazu Tanaka, Michiko Takeoka, Daisuke D. Komatsu et al. · 2024 · Molecular Oncology
Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies
Tasvi Daya, Andrea Breytenbach, Liang Gu, Mandeep Kaur · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development
A. T. Schneider, C. Köppe, E. Crouchet, A. Papargyriou, Michael T Singer, Veronika Büttner, Leonie Keysberg, M. Szydlowska, F. Jühling, Julien Moehlin et al. · 2025 · Nature Communications
Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy
Wei Wang, Atif Zafar, Mehrdad Rajaei, Ruiwen Zhang · 2020 · Cells
M-Ras is Muscle-Ras, Moderate-Ras, Mineral-Ras, Migration-Ras, and Many More-Ras
Takeshi Endo · 2020 · Experimental Cell Research
Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
Yongde Luo, Xiaokun Li, Jianjia Ma, James L. Abbruzzese, Weiqin Lu · 2021 · Cancers
Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma
Margaret L. Musser, Chad M. Johannes · 2021 · BMC Veterinary Research
DNAJA1 Dysregulates Metabolism Promoting an Antiapoptotic Phenotype in Pancreatic Ductal Adenocarcinoma
Heidi E. Roth, Fatema Bhinderwala, Rodrigo Franco, You Zhou, Robert Powers · 2021 · Journal of Proteome Research
KRAS gene polymorphisms are associated with the risk of glioma: a two-center case-control study
Qian Guan, Yuan Li, Ao Lin, Huiran Lin, Xiaokai Huang, Jichen Ruan, Zhenjian Zhuo · 2021 · Translational Pediatrics
Clinical M2 macrophages-related genes to aid therapy in pancreatic ductal adenocarcinoma
Qianhui Xu, Shaohuai Chen, Yuanbo Hu, Wen Huang · 2021 · Cancer Cell International
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer
Foote, Jeremy B., Mattox, Tyler E., Keeton, Adam B., Chen, Xi, Smith, Forrest, Berry, Kristy L., Holmes, Thomas, Wang, Junwei, Huang, Chung-Hui, Ward, Antonio B. et al. · 2023
Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid‑based antisense: A potential new drug candidate for pancreatic cancer
Shai, Ayelet, Galouk, Evleen, Miari, Reem, Tareef, Hala, Sammar, Marei, Zeidan, Mouhammad, Rayan, Anwar, Falah, Mizied · 2022 · Oncology Letters
Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
Peinan Liu, Juliette Jacques, Chang‐Il Hwang · 2024 · Epigenomes
Interleukin-1 signaling in solid organ malignancies
Austin R. Dosch, Samara P. Singh, Nagaraj S. Nagathihalli, Jashodeep Datta, Nipun B. Merchant · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H 2S axis and contributes to pancreatic cancer growth
Kun Fan, Shulong Zhang, Xiaojian Ni, Sheng Shen, Jiwen Wang, Wentao Sun, Tao Suo, Han Liu, Xiaoling Ni, Houbao Liu · 2022 · Acta Biochimica et Biophysica Sinica
Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for Pancreatic Ductal Adenocarcinoma Treatment
Yukun Huang, Yu Chen, Songlei Zhou, Laozhi Xie, Kaifan Liang, Jianpei Xu, Qian Zhang, Huan Chen, Dayuan Wang, Qingxiang Song et al. · 2023 · ACS Nano
Advancements in Preclinical Models of Pancreatic Cancer
Philip Salu, Katie M. Reindl · 2024 · Pancreas
A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment
Eleni-Myrto Trifylli, Anastasios G. Kriebardis, Evangelos Koustas, Nikolaos Papadopoulos, Sotirios P. Fortis, Vassilis L. Tzounakas, Alkmini T. Anastasiadi, Panagiotis Sarantis, Sofia Vasileiadi, Ariadne Tsagarakis et al. · 2024 · International Journal of Molecular Sciences
Genetic Signature of Human Pancreatic Cancer and Personalized Targeting
Stephan J. Reshkin, Rosa Angela Cardone, Tomas Koltai · 2024 · Cells
Comprehensive Detection of Single Amino Acid Variants and Evaluation of Their Deleterious Potential in a PANC-1 Cell Line
Zhijing Tan, Jianhui Zhu, Paul M. Stemmer, Liangliang Sun, Zhichang Yang, Kendall Schultz, Matthew J. Gaffrey, Anthony J. Cesnik, Xinpei Yi, Xiaohu Hao et al. · 2020 · Journal of Proteome Research
CEP164 Deficiency Causes Hyperproliferation of Pancreatic Cancer Cells
Tetsuo Kobayashi, Kosuke Tanaka, Yu Mashima, Ayano Shoda, Mio Tokuda, Hiroshi Itoh · 2020 · Frontiers in Cell and Developmental Biology
IDENTIFICATION OF MUTANT K-RAS IN PITUITARY MACROADENOMA
Veronica Aran, Manoela Heringer, Paulo José da Mata Pereira, Leandro Kasuki, Renan Lyra Miranda, Felipe Da Matta Andreiuolo, Leila M C Chimelli, Paulo Niemeyer Filho, Mônica R. Gadelha, Vivaldo Moura‐Neto · 2021 · Pituitary